Study identification

EU PAS number

EUPAS48420

Study ID

48421

Official title and acronym

Drug utilization of temozolomide with or without antiepileptic drugs in patients with malignant gliomas in the Tuscany region

DARWIN EU® study

No

Study countries

Italy

Study status

Finalised
Research institutions and networks

Institutions

University of Pisa Pisa, Azienda Ospedaliera Universitaria Senese Siena, University of Siena Siena

Contact details

Andrea Spini

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

No funding
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable